19-51338035-G-A
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6
The NM_001163922.3(VSIG10L):c.1903C>T(p.Arg635Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000387 in 1,551,528 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001163922.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VSIG10L | NM_001163922.3 | c.1903C>T | p.Arg635Trp | missense_variant | 6/10 | ENST00000335624.5 | NP_001157394.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VSIG10L | ENST00000335624.5 | c.1903C>T | p.Arg635Trp | missense_variant | 6/10 | 5 | NM_001163922.3 | ENSP00000335623 | P1 | |
VSIG10L | ENST00000600663.1 | n.521C>T | non_coding_transcript_exon_variant | 3/7 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152154Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000639 AC: 10AN: 156608Hom.: 0 AF XY: 0.0000843 AC XY: 7AN XY: 83008
GnomAD4 exome AF: 0.0000407 AC: 57AN: 1399374Hom.: 1 Cov.: 31 AF XY: 0.0000406 AC XY: 28AN XY: 690200
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152154Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74318
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 26, 2022 | The c.1903C>T (p.R635W) alteration is located in exon 6 (coding exon 6) of the VSIG10L gene. This alteration results from a C to T substitution at nucleotide position 1903, causing the arginine (R) at amino acid position 635 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Dec 01, 2022 | VSIG10L: BP4 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at